Radiation Oncology Chulolongkorn University

High Dose Preoperative Irradiation


[Previous Page] [Next Page] [Up] [Home Page]


¤×Í¡ÒéÒÂÃѧÊÕã¹¢¹Ò´·Õè > 4,000 cGy ¢Öé¹ä» «Ö觢¹Ò´¢Í§ÃѧÊÕ·ÕèãËéáµèÅФÃÑ駨ÐÍÂÙèÃÐËÇèÒ§
180-200 cGy ã¹·Ò§·ÄɯÕáÅéÇ »ÃÔÁÒ³ÃѧÊÕ¢¹Ò´¹Õé¨ÐÊÒÁÒö·ÓãËé¡é͹à¹×éÍÁÐàÃç§ÁÕ¢¹Ò´àÅç¡Å§ áÅСӨѴ microscopic cancer cell ·ÕèÍÂÙèã¹µèÍÁ¹éÓàËÅ×ͧ µÅÍ´¨¹à«ÅÅìÁÐàÃ秢¹Ò´àÅç¡ æ ·ÕèÍÂÙèÅÖ¡ã¹ÍØé§àªÔ§¡ÃÒ¹·Õè¡Ò÷ӼèҵѴà¢éÒäÁè¶Ö§ Íѹà»ç¹¤ÇÒÁËÇѧãËÁèÇèҨзÓãËéÁÕ¡ÒäǺ¤ØÁâä੾ÒзÕèáÅÐÍѵÃÒ
¡ÒÃÃÍ´ªÕÇÔµ ·Õè´Õ¢Ö鹡ÇèÒ¡ÒÃãªé low dose ËÃ×Í moderate dose preoperative irradiation
ÁÕÃÒ§ҹ¡ÒÃÈÖ¡ÉÒ·Ñ駷Õèà»ç¹ nonrandomized and randomized studies (µÒÃÒ§·Õè 5) ·ÕèáÊ´§¶Ö§»ÃÐ⪹ì¢Í§¡ÒÃãªé high dose preoperative radiation â´Â੾ÒÐã¹¼Ùé»èÇÂÁÐàÃç§ÅÓäÊéãË­èÊèǹ rectum
·Õèà»ç¹ "unfavorable" cancers ¤×Í¡ÅØèÁ·ÕèÁÕ¡ÒÃÅØ¡ÅÒÁ¢Í§ÁÐàÃç§ÍÍ¡¹Í¡¼¹Ñ§¢Í§ÅÓäÊé ÁÐàÃç§à¡ÒеԴ¡Ñº
ÍÇÑÂÇТéÒ§à¤Õ§áÅÐ/ËÃ×ÍÁÕ¡ÒÃá¾Ãè¡ÃШÒ¢ͧÁÐàÃç§à¢éÒÊÙèµèÍÁ¹éÓàËÅ×ͧ (µÒÃÒ§·Õè 6) àªè¹ ¡ÒÃÈÖ¡ÉҢͧ Stevens áÅÐ Colleagues11 ·Õè The University of Oregon ¼Ùé»èÇÂÁÐàÃç§ÅÓäÊéãË­èÊèǹ rectum ·Õèà»ç¹¡ÅØèÁ unfavorable â´Â¡ÒéÒÂÃѧÊÕ¢¹Ò´ 5,000-6,000 cGy ã¹ÃÐÂÐàÇÅÒ 5-8 ÊÑ»´ÒËì áÅéǵÒÁ´éÇ¡Ò÷ӼèҵѴËÅѧ¨Ò¡©ÒÂÃѧÊÕáÅéÇ 4-7 ÊÑ»´ÒËì ¾ºÇèÒÍѵÃÒ¡ÒÃÃÍ´ªÕÇÔµËÅѧ¡ÒÃÃÑ¡ÉÒ·Õè 5 »Õ à·èҡѺ 53% àÁ×èÍà·Õº¡Ñº 38% 㹡ÅØèÁ·Õè·Ó¼èҵѴÍÂèÒ§à´ÕÂÇ ËÃ×ͨҡ¡ÒÃÃÒ§ҹ¢Í§ Mendenhall12 et al ·Õè The University of Florida â´Â¡ÒÃãªé preoperative irradiation ´éÇ»ÃÔÁÒ³ÃѧÊÕ¢¹Ò´ 4,500 cGy ã¹ÃÐÂÐàÇÅÒ 5 ÊÑ»´ÒËì (l80 cGy/fraction) ¾ºÇèÒäÁèÁÕà«ÅÅìÁÐàÃç§ËŧàËÅ×ÍÍÂÙèàÅÂã¹à¹×éÍàÂ×èÍ·Õè·Ó¼èҵѴÍÍ¡ÁÒ¶Ö§ 11% áÅÐÍغѵԡÒâͧ¡ÒÃÅØ¡ÅÒÁ¢Í§ÁÐàÃç§ä»·ÕèµèÍÁ¹éÓàËÅ×ͧ (positive pelvic lymph node) ¡çŴŧ¤ÃÖè§Ë¹Öè§ (l9% VS 38%) àÁ×èÍà·Õº¡Ñº¡ÅØèÁ·Õè·Ó¼èҵѴÍÂèÒ§à´ÕÂÇ ¹Í¡¨Ò¡¹Õé ÍغѵԡÒâͧ¡ÒáÓàÃÔº¢Í§âä੾ÒзÕèáÅÐÍѵÃÒ¡ÒÃÃÍ´ªÕÇÔµ·Õè 5 »Õ à·èҡѺ 8% VS 29% (P=0.0l5) áÅÐ 71% VS 41% (P=0.008) àÁ×èÍà·Õº¡Ñº¡Ò÷ӼèҵѴÍÂèÒ§à´ÕÂǵÒÁÅӴѺ áÅзÕèÊӤѭäÁ辺ÇèÒÁÕÀÒÇÐá·Ã¡«é͹ª¹Ô´à©Õº¾Åѹ ã¹¼Ùé»èÇ·Õèä´éÃѺ¡ÒéÒÂÃѧÊÕ¡è͹¡Ò÷ӼèҵѴ
¨Ò¡¡ÒÃÈÖ¡ÉÒµèÒ§ æ àËÅèÒ¹Õé à»ç¹·Õè»ÃÒ¡¯á¹èªÑ´áÅéÇÇèÒ»ÃÐ⪹ì¢Í§¡ÒÃãªé High dose preoperative radiation ¡ç¤×Í¡ÒÃÅ´ÍغѵԡÒâͧ¡ÒáÓàÃÔº¢Í§âäã¹ÍØé§à ªÔ§¡ÃÒ¹ áÅÐÍÒ¨¨ÐÁռŵèÍ¡ÒÃà¾ÔèÁÍѵÃÒ¡ÒÃÁÕªÕÇÔµÃÍ´¢Í§¼Ùé»èÇ â´Â੾ÒÐÍÂèÒ§ÂÔè§ã¹¡ÅØèÁ¼Ùé»èÇ·Õèà»ç¹ fixed rectal cancer áÅÐ distal rectal cancer


µÒÃÒ§·Õè 5 Results of High-Dose Preoperative Radiation in Rectal cancer


Study Dose(Gy) Local recur, RT(%) Local recur, Surgery(%) 5-yr survival, RT(%) 5-yr survival, Surgery(%)
Mendenhall(12) 45 8 29 71 41
Fortier(14) 45 16 40 52 48
Stevens et al(11) 50-60 0 18 53 38
Kodner et al(15) 45 2 24 86 -
Mohiuddin et al(16) 45-60 15 36 72 -
Kligerman(13) 45 - - 41 25


µÒÃÒ§·Õè 6 Clinical Evaluation of Cancer of the Rectum


  Favorable Unfavorable
Tumor size <4cm >= 4cm
Stage >= B2
Fixation Mobile Fixed
Ulceration Absent Present
Lymph nodes Absent Present
Histology Differentiated Undifferentiated


Randomized study ·ÕèÃÒ§ҹâ´Â Kligerman et al13 «Öè§à»ÃÕºà·Õº¡ÒÃãËé¡ÒéÒÂÃѧÊÕ ¢¹Ò´ 4,500 cGy ã¹ÃÐÂÐàÇÅÒ 5 ÊÑ»´ÒËì ¡è͹¡Ò÷ӼèҵѴ ¡Ñº¡ÅØèÁ·Õè·Ó¼èҵѴÍÂèÒ§à´ÕÂÇ ¾ºÇèÒ¡ÅØèÁ·Õèä´éÃѺ¡ÒéÒÂÃѧÊÕ ¨ÐÁÕÍѵÃÒ¡ÒÃÃÍ´ªÕÇÔµ·Õè 5 »Õ 41% à·Õº¡Ñº 25% 㹡ÅØèÁ·Õè·Ó¼èҵѴÍÂèÒ§à´ÕÂÇ


[Previous] Moderate Dose Preoperative Irradiation
[Next] High-Dose Radiation and Sphincter Preservation
[Up] Preoperative Radiotherapy in Rectal Adenocarcinoma
[Home] Home Page

Last modified on 25 October 1996